Source: http://www.asmscience.org/content/book/10.1128/9781555815981.ch38
Timestamp: 2019-04-21 00:24:00+00:00

Document:
Replication strategy of mumps virus.
1. Afzal, M. A.,, J. Buchanan,, J. A. Dias,, M. Cordeiro,, M. L. Bentley,, C. A. Shorrock, and, P. D. Minor. 1997. RT-PCR based diagnosis and molecular characterisation of mumps viruses derived from clinical specimens collected during the 1996 mumps outbreak in Portugal. J. Med. Virol. 52: 349– 353.
2. Alhaj, S.,, I. Ozyylmaz,, G. Altun, and, H. Cam. 2007. Eyelid, facial and presternal edema in mumps. Pediatr. Infect. Dis. J. 26: 661.
3. Alp, H.,, H. Tan,, Z. Orbak, and, H. Keskin. 2005. Acute hydrocephalus caused by mumps meningoencephalitis. Pediatr. Infect. Dis. J. 24: 657– 658.
4. Anderson, R. M.,, J. A. Crombie, and, B. T. Grenfell. 1987. The epidemiology of mumps in the UK: a preliminary study of virus transmission, herd immunity and the potential impact of immunization. Epidemiol. Infect. 99: 65– 84.
6. Arita, M.,, Y. Ueno, and, Y. Masuyama. 1981. Complete heart block in mumps myocarditis. Br. Heart J. 46: 342– 344.
7. Aurpibul, L.,, T. Puthanakit,, T. Sirisanthana, and, V. Sirisanthana. 2007. Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy. Clin. Infect. Dis. 45: 637– 642.
8. Azimi, P. H.,, H. G. Cramblett, and, R. E. Hayers. 1969. Mumps meningoencephalitis in children. JAMA 207: 509– 512.
9. Azimi, P. H.,, S. Shaban,, M. D. Hilty, and, R. E. Haynes. 1975. Mumps meningoencephalitis: prolonged abnormality of cerebrospinal fluid. JAMA 234: 1161– 1162.
10. Bang, H. O.,, and J. Bang. 1943. Involvement of the central nervous system in mumps. Acta Med. Scand. 113: 487– 505.
11. Bansal, R.,, J. Kalita,, U. K. Misra, and, J. Kishore. 1998. Myelitis: a rare presentation of mumps. Pediatr. Neurosurg. 28: 204– 206.
12. Basşekim, C. C.,, E. Kizilkaya,, Z. Pekkafali,, K. V. Baykal, and, A. F. Karsli. 2000. Mumps epididymo-orchitis: sonography and color Doppler sonographic findings. Abdom. Imaging 25: 322– 325.
13. Beard, C. M.,, R. C. Benson,, P. P. Kelalis,, L. R. Eve-back, and, L. T. Kurland. 1977. The incidence and outcome of mumps orchitis in Rochester, Minnesota, 1935–1974. Mayo Clin. Proc. 52: 3– 7.
14. Beardwell, A. 1969. Facial palsy due to the mumps virus. Br. J. Clin. Pract. 23: 37– 38.
15. Bern, C.,, H. Barucha, and, P. S. Patil. 1992. Parotid disease and human immunodeficiency virus infection in Zambia. Br. J. Surg. 79: 768– 770.
16. Bistrian, B.,, C. A. Phillips, and, I. S. Kaye. 1972. Fatal mumps meningoencephalitis. JAMA 222: 478– 479.
17. Boddicker, J. D.,, P. A. Rota,, T. Kreman,, A. Wangeman,, L. Lowe,, K. B. Hummel,, R. Thompson,, W. J. Bellini,, M. Pentella, and, L. E. Desjardin. 2007. Real-time reverse transcription-PCR assay for detection of mumps virus RNA in clinical specimens. J. Clin. Microbiol. 45: 2902– 2908.
18. Bonnet, M. C.,, A. Dutta,, C. Weinberger, and, S. A. Plotkin. 2006. Mumps vaccine virus strains and aseptic meningitis. Vaccine 24: 7037– 7045.
19. Brown, E. H.,, and W. H. Dunnett. 1974. A retrospective survey of the complications of mumps. J. R. Coll. Gen. Practitioners 24: 552– 556.
20. Brunnell, P. A. 2006. Mumps outbreak 2006: evaluating vaccine efficacy complicated by disease’s characteristics. Infect. Dis. Child. 196: 24– 26.
21. Bruyn, H. B.,, H. M. Sexton, and, H. D. Brainend. 1957. Mumps meningoencephalitis: a clinical review of 119 cases with one death. Calif. Med. 86: 153– 160.
22. Casella, R.,, B. Leibundgut,, K. Lehmann, and, T. C. Gasser. 1997. Mumps orchitis: report of a mini-epidemic. J. Urol. 158: 2158– 2161.
23. Centers for Disease Control. 1989. Mumps—United States, 1985–1988. Morb. Mortal. Wkly. Rep. 38: 101– 105.
24. Centers for Disease Control and Advisory Committee on Immunization Practices. 1989. Mumps prevention. Morb. Mortal. Wkly. Rep. 38: 388– 400.
25. Centers for Disease Control and Prevention. 1996. Update: vaccine side effects, adverse reactions, contraindications, and precautions. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly. Rep. Recomm. Rep. 45: 1– 35.
26. Centers for Disease Control and Prevention. 2006. Brief report: update: mumps activity—United States, January 1–October 7, 2006. Morb. Mortal. Wkly. Rep. 55: 1152– 1153.
27. Centers for Disease Control and Prevention. 2006. Notice to readers: updated recommendations of the Advisory Committee on Immunization Practices (ACIP) for the control and elimination of mumps. Morb. Mortal. Wkly. Rep. 55: 629– 630.
28. Centers for Disease Control and Prevention. 2007. Recommended immunization schedules for persons aged 0–18 years—United States, 2007. Morb. Mortal. Wkly. Rep. 55: Q1– Q4.
29. Centers for Disease Control and Prevention. 1995. Mumps surveillance—United States, 1988–1993. Morb. Mortal. Wkly. Rep. 44 (SS-3) : 1– 14.
30. Cochi, S. L.,, S. R. Preblud, and, W. A. Orenstein. 1988. Perspectives on the relative resurgence of mumps in the United States. Am. J. Dis. Child. 142: 499– 507.
31. Davidkin, I.,, S. Jokinen,, M. Broman,, P. Leinikki, and, H. Peltola. 2008. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J. Infect. Dis. 197: 950– 956.
32. Davidkin, I.,, S. Jokinen,, A. Paananen,, P. Leinikki, and, H. Peltola. 2005. Etiology of mumps-like illnesses in children and adolescents vaccinated for measles, mumps, and rubella. J. Infect. Dis. 191: 719– 723.
33. Davidson, W. L.,, E. B. Buynak,, M. B. Leagus,, J. E. Whitman, and, M. R. Hilleman. 1967. Vaccination of adults with live attenuated mumps virus vaccine. JAMA 201: 995– 998.
34. Dayan, G. H.,, P. Quinlisk,, A. A. Parker,, A. E. Barskey,, M. L. Harris,, J. M. Hill Schwartz,, K. Hunt,, C. G. Filey,, D. P. Leschinsky,, A. L. O’Keefe, and, J. Clayton. 2008. Recent resurgence of mumps in the United States. N. Engl. J. Med. 358: 1580– 1589.
35. Dourado, I.,, S. Cunha,, M. G. Teixeira,, C. P. Farrington,, A. Melo,, R. Lucena, and, M. L. Barreto. 2000. Outbreak of aseptic meningitis associated with mass vaccination with a Urabe-containing measles-mumps-rubella vaccine: implications for immunization programs. Am. J. Epidemiol. 151: 524– 530.
37. Ehrengut, W.,, and M. Schwartau. 1977. Mumps orchitis and testicular tumours. Br. Med. J. 2: 191.
38. Elango, N.,, T. Varsanyi,, J. Kövamees, and, E. Norrby. 1988. Molecular cloning and characterization of six genes, determination of gene order and intergenic sequences and leader sequence of mumps virus. J. Gen. Virol. 69: 2893– 2900.
39. Elliott, G. D.,, M. A. Afzal,, S. J. Martin, and, B. K. Rima. 1989. Nucleotide sequence of the matrix, fusion and putative SH protein genes of mumps virus and their deduced amino acid sequences. Virus Res. 12: 61– 75.
40. Elliott, G. D.,, R. P. Yeo,, M. A. Afzal,, E. J. B. Simpson,, J. A. Curran, and, B. K. Rima. 1990. Strain variable editing during transcription of the P gene of mumps virus may lead to the generation of non-structural proteins NS1 (V) and NS2. J. Gen. Virol. 71: 1555– 1560.
41. Emerson, C.,, W. W. Dinsmore, and, S. P. Quah. 2007. Are we missing mumps epididymo-orchitis? Int. J. STD AIDS 18: 341– 342.
42. Erpenbach, K. H. 1991. Systemic treatment with interferon-alpha 2B: an effective method to prevent sterility after bilateral mumps orchitis. J. Urol. 146: 54– 56.
43. Falk, W. A.,, K. Buchan,, M. Dow,, J. Z. Garson,, E. Hill,, M. Nosal,, M. Tarrant,, R. C. Westbury, and, F. M. White. 1989. The epidemiology of mumps in southern Alberta 1980–1982. Am. J. Epidemiol. 130: 736– 749.
44. Forsberg, P.,, A. Fryden,, H. Link, and, C. Orvell. 1986. Viral IgM and IgG antibody synthesis within the central nervous system in mumps meningitis. Acta Neurol. Scand. 73: 372– 380.
45. Foster, R. E.,, C. Y. Lowder,, D. M. Meisler,, G. S. Kosmorsky, and, B. Baetz-Greenwalt. 1990. Mumps neuroretinitis in an adolescent. Am. J. Ophthalmol. 110: 91– 92.
46. Freeman, R.,, and M. H. Hambling. 1980. Serologic studies on 40 cases of mumps virus infection. J. Clin. Pathol. 33: 28– 32.
47. Galinski, M. S.,, and S. L. Wechsler. 1991. The molecular biology of the paramyxovirus genus, p. 41–82. In D. W. Kingbury (ed.), The Paramyxoviruses. Plenum Press, New York, NY.
48. Garcia, A. G.,, J. M. Pereira,, N. Vidigal,, Y. Y. Lokato,, C. S. Pegado, and, J. P. Branco. 1980. Intrauterine infection with mumps virus. Obstet. Gynecol. 56: 756– 759.
49. Glikmann, G.,, M. Pedersen, and, C. H. Mordhorst. 1986. Detection of specific immunoglobulin M to mumps virus in serum and cerebrospinal fluid samples from patients with acute mumps infection, using an antibody capture enzyme immunoassay. Acta Pathol. Microbiol. Immunol. Scand. 94: 145– 156.
50. Gnann, J. W. 1994. Mumps virus, p. 555–562. In R. R. McKendall and, W. G. Stroop (ed.), Handbook of Neurovirology. Marcel Dekker Inc., New York, NY.
51. Gonzalez-Gil, J.,, M. T. Zarrabeitia,, E. Altuzarra,, I. Sanchez-Molina, and, R. Calvet. 2000. Hydrocephalus: a fatal late consequence of mumps encephalitis. J. Forensic Sci. 45: 204– 207.
52. Gordon, S. C.,, and C. B. Lauter. 1984. Mumps arthritis: a review of the literature. Rev. Infect. Dis. 6: 338– 343.
53. Gut, J. P.,, C. Lablache,, S. Behr, and, A. Kirn. 1995. Symptomatic mumps virus reinfections. J. Med. Virol. 45: 17– 23.
54. Haginoya, K.,, K. Ike,, K. Iinuma,, T. Yagi,, K. Kon,, H. Yokoyama, and, Y. Numazaki. 1995. Chronic progressive mumps virus encephalitis in a child. Lancet 346: 50.
55. Hall, R.,, and H. Richards. 1987. Hearing loss due to mumps. Arch. Dis. Child. 62: 189– 191.
56. Harel, L.,, J. Amir,, O. Reish,, A. H. Cohen,, I. Varsano, and, N. Varsano. 1990. Mumps arthritis in children. Pediatr. Infect. Dis. J. 9: 928– 929.
57. Herndon, R. M.,, R. T. Johnson,, L. E. Davis, and, L. R. Descalzi. 1974. Ependymitis in mumps virus meningitis. Electron microscopical studies of cerebrospinal fluid. Arch. Neurol. 30: 475– 479.
58. Hilleman, M. R.,, E. B. Buynak,, R. E. Weibel, and, J. Stokes. 1968. Live, attenuated mumps-virus vaccine. N. Engl. J. Med. 278: 227– 232.
59. Hiraiwa, K.,, K. Obara, and, A. Sato. 2005. Mumps virus-associated hemophagocytic syndrome. Emerg. Infect. Dis. 11: 343.
60. Hopkins, R. S.,, R. A. Jajosky,, P. A. Hall,, D. A. Adams,, F. J. Connor,, P. Sharp,, W. J. Anderson,, R. F. Fagan,, J. J. Aponte,, D. A. Nitschke,, C. A. Worsham,, N. Adekoya, and, M. H. Chang. 2005. Summary of notifiable diseases—United States, 2003. Morb. Mortal. Wkly. Rep. 52: 1– 85.
61. Houard, S.,, T. M. Varsanyi,, F. Milican,, E. Norrby, and, A. Bollen. 1995. Protection of hamsters against experimental mumps virus (MuV) infection by antibodies raised against the MuV surface glycoproteins expressed from recombinant vaccinia virus vectors. J. Gen. Virol. 76(Pt. 2) : 421– 423.
62. Ito, M.,, T. Go,, T. Okuno, and, H. Mikawa. 1991. Chronic mumps virus encephalitis. Pediatr. Neurol. 7: 467– 470.
63. Ito, Y.,, M. Tsurudome,, M. Hishiyama, and, A. Yamada. 1987. Immunological interrelationships among human and non-human paramyxoviruses revealed by immunoprecipitation. J. Gen. Virol. 68: 1289– 1297.
64. Jin, L.,, D. W. Brown,, P. A. Litton, and, J. M. White. 2004. Genetic diversity of mumps virus in oral fluid specimens: application to mumps epidemiological study. J. Infect. Dis. 189: 1001– 1008.
65. Jin, L.,, B. Rima,, D. Brown,, C. Orvell,, T. Tecle,, M. Afzal,, K. Uchida,, T. Nakayama,, J. W. Song,, C. Kang,, P. A. Rota,, W. Xu, and, D. Featherstone. 2005. Proposal for genetic characterisation of wild-type mumps strains: preliminary standardisation of the nomenclature. Arch. Virol. 150: 1903– 1909.
66. Johnstone, J. A.,, C. A. C. Ross, and, M. Dunn. 1972. Meningitis and encephalitis associated with mumps infection. Arch. Dis. Child. 47: 647– 651.
67. Kabakus, N.,, H. Aydinoglu,, S. A. Bakkaloglu, and, H. Yekeler. 1999. Mumps interstitial nephritis: a case report. Pediatr. Nephrol. 13: 930– 931.
68. Kancherla, V. S.,, and I. C. Hanson. 2006. Mumps resurgence in the United States. J. Allergy Clin. Immunol. 118: 938– 941.
69. Kanra, G.,, P. Isik,, A. Kara,, A. B. Cengiz,, G. Secmeer, and, M. Ceyhan. 2004. Complementary findings in clinical and epidemiologic features of mumps and mumps meningoencephalitis in children without mumps vaccination. Pediatr. Int. 46: 663– 668.
70. Kanra, G.,, A. Kara,, A. B. Cengiz,, P. Isik,, M. Ceyhan, and, A. Atas. 2002. Mumps meningoencephalitis effect on hearing. Pediatr. Infect. Dis. J. 21: 1167– 1169.
71. Kayan, A. 1990. Bilateral sensorineural hearing loss due to mumps. Br. J. Clin. Pathol. 44: 757– 759.
72. Khakoo, G. A.,, and G. Lack. 2000. Recommendations for using MMR vaccine in children allergic to eggs. BMJ 320: 929– 932.
73. Kilham, L.,, J. Levens, and, J. Enders. 1949. Nonparalytic poliomyelitis and mumps meningoencephalitis. JAMA 140: 934– 936.
74. Kimura, H.,, Y. Ando,, M. Shibata,, T. Abe, and, T. Morishima. 1993. T-cell receptor V alpha region usage in the cerebrospinal fluid of patients with mumps meningitis. J. Med. Virol. 41: 306– 311.
75. Koskiniemi, M.,, M. Donner, and, O. Pettay. 1983. Clinical appearance and outcome in mumps encephalitis in children. Acta Paediatr. Scand. 72: 603– 609.
76. Krause, C. H.,, K. Eastick, and, M. M. Ogilvie. 2006. Real-time PCR for mumps diagnosis on clinical specimens—comparison with results of conventional methods of virus detection and nested PCR. J. Clin. Virol. 37: 184– 189.
77. Krause, C. H.,, P. J. Molyneaux,, D. O. Ho-Yen,, P. McIntyre,, W. F. Carman, and, K. E. Templeton. 2007. Comparison of mumps-IgM ELISAs in acute infection. J. Clin. Virol. 38: 153– 156.
78. Kubar, A.,, M. Yapar,, B. Besirbellioglu,, I. Y. Avci, and, C. Guney. 2004. Rapid and quantitative detection of mumps virus RNA by one-step real-time RT-PCR. Diagn. Microbiol. Infect. Dis. 49: 83– 88.
79. Kubota, T.,, N. Yokosawa,, S. Yokota,, N. Fujii,, M. Tashiro, and, A. Kato. 2005. Mumps virus V protein antagonizes interferon without the complete degradation of STAT1. J. Virol. 79: 4451– 4459.
80. Kurtz, J. B.,, A. H. Tomlinson, and, J. Pearson. 1982. Mumps virus isolated from a fetus. Br. Med. J. 284: 471.
81. Lane, T. M.,, and J. Hines. 2006. The management of mumps orchitis. BJU Int. 97: 1– 2.
82. Lavi, S.,, B. Zimmerman,, G. Koren, and, R. Gold. 1990. Administration of measles, mumps, and rubella virus vaccine (live) to egg allergic children. JAMA 263: 269– 271.
83. Lemon, K.,, B. K. Rima,, S. McQuaid,, I. V. Allen, and, W. P. Duprex. 2007. The F gene of rodent brain-adapted mumps virus is a major determinant of neurovirulence. J. Virol. 81: 8293– 8302.
84. Levitt, L. P.,, T. A. Rich,, S. W. Kindle,, A. L. Lewis,, E. H. Gates, and, J. O. Bond. 1970. Central nervous system mumps. Neurology 20: 829– 834.
85. Linde, G. A.,, M. Granstrom, and, C. Örvell. 1987. Immunoglobulin class and immunoglobulin G subclass enzyme-linked immunosorbent assays compared with microneutralization assay for serodiagnosis of mumps infection and determination of immunity. J. Clin. Microbiol. 25: 1653– 1658.
86. Löve, A.,, T. Andersson,, E. Norrby, and, K. Kristenssan. 1987. Mumps virus infection of dissociated rodent spinal ganglion in vitro. Expression and disappearance of viral structural protein in neurons. J. Gen. Virol. 68: 1755– 1759.
87. Löve, A.,, R. Rydbeck,, K. Kristensson,, C. Örvell, and, E. Norrby. 1985. Hemagglutinin-neuraminidase glycoprotein as a determinant of pathogenicity in mumps virus hamster encephalitis: analysis of mutants selected with monoclonal antibodies. J. Virol. 53: 67– 74.
88. Majda-Stanislawska, E. 2000. Mumps cerebellitis. Eur. Neurol. 43: 117.
89. Malik, T.,, C. Wolbert,, J. Mauldin,, C. Sauder,, K. M. Carbone, and, S. A. Rubin. 2007. Functional consequences of attenuating mutations in the haemagglutinin neuraminidase, fusion and polymerase proteins of a wildtype mumps virus strain. J. Gen. Virol. 88: 2533– 2541.
90. Manson, A. L. 1990. Mumps orchitis. Urology 36: 355– 358.
91. Martin, R.,, A. Vallbracht, and, H. W. Kreth. 1991. Interferon-gamma secretion by in vivo activated cytotoxic T lymphocytes from the blood and cerebrospinal fluid during mumps meningitis. J. Neuroimmunol. 33: 191– 198.
92. Masarani, M.,, H. Wazait, and, M. Dinneen. 2006. Mumps orchitis. J. R. Soc. Med. 99: 573– 575.
93. Matsukuma, E.,, Z. Kato,, K. Orii,, T. Asano,, K. Orii,, E. Matsui,, H. Kaneko, and, N. Kondo. 2008. Acute mumps cerebellitis with abnormal findings in MRI diffusion-weighted images. Eur. J. Pediatr. 167: 829– 830.
94. Mauldin, J.,, K. Carbone,, H. Hsu,, R. Yolken, and, S. Rubin. 2005. Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays. J. Clin. Microbiol. 43: 4847– 4851.
95. McKenna, M. J. 1997. Measles, mumps, and sensorineural hearing loss. Ann. N. Y. Acad. Sci. 830: 291– 298.
96. McLean, D. M.,, S. J. Walker, and, G. A. McNaughton. 1964. Mumps meningoencephalitis, Toronto 1963. Can. Med. Assoc. J. 90: 458– 462.
97. McQuone, S. J. 1999. Acute viral and bacterial infections of the salivary glands. Otolaryngol. Clin. N. Am. 32: 793– 811.
98. Merz, D. C.,, A. C. Server,, M. N. Waxham, and, J. S. Wolinsky. 1983. Biosynthesis of mumps virus F glycoprotein: nonfusing strains efficiently cleave the F glycoprotein precursor. J. Gen. Virol. 64: 1457– 1467.
99. Muhlemann, K. 2004. The molecular epidemiology of mumps virus. Infect. Genet. Evol. 4: 215– 219.
100. Murray, H. G. S.,, C. M. B. Field, and, W. J. McLeod. 1960. Mumps meningo-encephalitis. Br. Med. J. 1: 1850– 1853.
101. Ni, J.,, N. E. Bowles,, Y. H. Kim,, G. Demmler,, D. Kearney,, J. T. Bricker, and, J. A. Towbin. 1997. Viral infection of the myocardium in endocardial fibroelastosis. Molecular evidence for the role of mumps virus as an etiologic agent. Circulation 95: 133– 139.
102. Nigro, G.,, F. Nanni, and, M. Midulla. 1986. Determination of vaccine-induced and naturally acquired classspecific antibodies by two indirect ELISAs. J. Virol. Methods 13: 91– 106.
103. Okazaki, K.,, K. Tanabayashi,, K. Takeuchi,, M. Hishiyama,, K. Okazaki, and, A. Yamada. 1992. Molecular cloning and sequence analysis of the mumps virus gene encoding the L protein and the trailer sequence. Virology 188: 926– 930.
104. Onal, S.,, and E. Toker. 2005. A rare ocular complication of mumps: kerato-uveitis. Ocul. Immunol. Inflamm. 13: 395– 397.
105. Palacios, G.,, O. Jabado,, D. Cisterna,, F. de Ory,, N. Renwick,, J. E. Echevarria,, A. Castellanos,, M. Mosquera,, M. C. Freire,, R. H. Campos, and, W. I. Lipkin. 2005. Molecular identification of mumps virus genotypes from clinical samples: standardized method of analysis. J. Clin. Microbiol. 43: 1869– 1878.
106. Peltola, H.,, P. S. Kulkarni,, S. V. Kapre,, M. Paunio,, S. S. Jadhav, and, R. M. Dhere. 2007. Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Clin. Infect. Dis. 45: 459– 466.
107. Pipkin, P. A.,, M. A. Afzal,, A. B. Heath, and, P. D. Minor. 1999. Assay of humoral immunity to mumps virus. J. Virol. Methods 79: 219– 225.
108. Poggio, G. P.,, C. Rodriguez,, D. Cisterna,, M. C. Freire, and, J. Cello. 2000. Nested PCR for rapid detection of mumps virus in cerebrospinal fluid from patients with neurological diseases. J. Clin. Microbiol. 38: 274– 278.
109. Pringle, C. R. 1991. The genetics of paramyxoviruses, p. 1–39. In D. W. Kingbury (ed.), The Paramyxoviruses. Plenum Press, New York, NY.
110. Rafiefard, F.,, B. Johansson,, T. Tecle, and, C. Orvell. 2005. Characterization of mumps virus strains with varying neurovirulence. Scand. J. Infect. Dis. 37: 330– 337.
111. Reisinger, K. S.,, M. L. Brown,, J. Xu,, B. J. Sullivan,, G. S. Marshall,, B. Nauert,, D. O. Matson,, P. E. Silas,, F. Schodel,, J. O. Gress, and, B. J. Kuter. 2006. A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax. Pediatrics 117: 265– 272.
112. Ritter, B. S. 1958. Mumps meningoencephalitis. J. Pediatr. 52: 424– 432.
113. Rubin, S. A.,, M. A. Afzal,, C. L. Powell,, M. L. Bentley,, G. R. Auda,, R. E. Taffs, and, K. M. Carbone. 2005. The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans: an international collaborative study. J. Infect. Dis. 191: 1123– 1128.
114. Rubin, S. A.,, G. Amexis,, M. Pletnikov,, Z. Li,, J. Vanderzanden,, J. Mauldin,, C. Sauder,, T. Malik,, K. Chumakov, and, K. M. Carbone. 2003. Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype. J. Virol. 77: 11616– 11624.
115. Russell, R. R.,, and J. C. Donald. 1958. The neurological complications of mumps. Br. Med. J. 2: 27– 30.
116. Rüther, U.,, S. Stilz,, E. Röhl,, C. Nunnensiek,, J. Rassweiler,, U. Dörr, and, P. Jipp. 1995. Successful interferon-alpha 2a therapy for a patient with acute mumps orchitis. Eur. Urol. 27: 174– 176.
117. Schlegel, M.,, J. J. Osterwalder,, R. L. Galeazzi, and, P. L. Vernazza. 1999. Comparative efficacy of three mumps vaccines during disease outbreak in Eastern Switzerland: cohort study. BMJ 319: 352.
118. Server, A. C.,, D. C. Merz,, M. N. Waxham, and, J. S. Wolinsky. 1982. Differentiation of mumps virus strains with monoclonal antibody to the HN glycoprotein. Infect. Immun. 35: 179– 186.
119. Siegel, M. S. 1973. Congenital malformations following chickenpox, measles, mumps, and hepatitis. Results of a cohort study. JAMA 226: 1521.
120. Soberman, N.,, J. C. Leonidas,, W. E. Berdon,, V. Bonagura,, J. O. Haller,, M. Posher, and, L. Mandel. 1991. Parotid enlargement in children seropositive for human immunodeficiency virus: imaging findings. Am. J. Roentgenol. 157: 553– 556.
121. Sosin, D. M.,, S. L. Cochi,, R. A. Gunn,, C. E. Jennings, and, S. R. Preblud. 1989. Changing epidemiology of mumps and its impact on university campuses. Pediatrics 84: 779– 784.
122. Sullivan, K. M.,, T. J. Halpin,, J. S. Marks, and, R. Kim-Farley. 1985. Effectiveness of mumps vaccine in a school outbreak. Am. J. Dis. Child. 139: 909– 912.
123. Takeuchi, K.,, K. Tanabayashi,, M. Hishiyama, and, A. Yamada. 1996. The mumps virus SH protein is a membrane protein and not essential for virus growth. Virology 225: 156– 162.
124. Takeuchi, K.,, K. Tanabayashi,, M. Hishiyama,, A. Yamada, and, A. Sigiura. 1991. Variations of nucleotide sequences and transcription of the SH gene among mumps virus strains. Virology 181: 364– 366.
125. Takimoto, T.,, G. L. Taylor,, H. C. Connaris,, S. J. Cren-nell, and, A. Portner. 2002. Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion. J. Virol. 76: 13028– 13033.
126. Tanabayashi, K.,, K. Takeuchi,, M. Hishiyama,, A. Yamada,, M. Tsurudome,, Y. Ho, and, A. Sugiura. 1990. Nucleotide sequence of the leader and nucleocapsid protein gene of mumps virus and epitope mapping with the in vitro expressed nucleocapsid protein. Virology 177: 124– 130.
127. Tanabayashi, K.,, K. Takeuchi,, K. Okazaki,, M. Hishiyama, and, A. Yamada. 1992. Expression of mumps virus glycoproteins in mammalian cells from cloned cDNAs: both F and HN proteins are required for cell fusion. Virology 187: 801– 804.
128. Tanabayashi, K.,, K. Takeuchi,, K. Okazaki,, M. Hishiyama, and, A. Yamada. 1993. Identification of an amino acid that defines the fusogenicity of mumps virus. J. Virol. 67: 2928– 2931.
129. Uchida, K.,, M. Shinohara,, S. Shimada,, Y. Segawa,, R. Doi,, A. Gotoh, and, R. Hondo. 2005. Rapid and sensitive detection of mumps virus RNA directly from clinical samples by real-time PCR. J. Med. Virol. 75: 470– 474.
130. Ukkonen, P.,, O. Vaisanen, and, K. Penttinen. 1980. Enzyme-linked immunosorbent assay for mumps and parainfluenza type 1 immunoglobulin G and immunoglobulin M antibodies. J. Clin. Microbiol. 11: 319– 323.
131. Uno, M.,, T. Takano,, T. Yamano, and, M. Shimada. 1997. Age-dependent susceptibility in mumps-associated hydrocephalus: neuropathologic features and brain barriers. Acta Neuropathol. 94: 207– 215.
132. Utz, J. P.,, V. N. Houk, and, D. W. Alling. 1964. Clinical and laboratory studies of mumps. IV. Viruria and abnormal renal function. N. Engl. J. Med. 270: 1283– 1286.
133. Vandvik, B.,, E. Norrby,, J. Steen-Johnsen, and, K. Stensvold. 1978. Mumps meningitis: prolonged pleocytosis and occurrence of mumps virus-specific oligoclonal IgG in the cerebrospinal fluid. Eur. Neurol. 17: 13– 22.
134. Venketasubramanian, N. 1997. Transverse myelitis following mumps in an adult—a case report with MRI correlation. Acta Neurol. Scand. 96: 328– 331.
135. Viola, L.,, A. Chiaretti,, M. Castorina,, L. Tortorolo,, M. Piastra,, A. Villani,, P. Valentini, and, G. Polidori. 1998. Acute hydrocephalus as a consequence of mumps meningoencephalitis. Pediatr. Emerg. Care 14: 212– 214.
136. Vuori, M.,, E. A. Lahikainen, and, T. Peltonen. 1962. Perceptive deafness in connection with mumps. Acta Otolaryngol. 55: 231.
137. Waxham, M. N.,, J. Aronowski,, A. C. Server,, J. S. Wolinsky,, J. A. Smith, and, H. M. Goodman. 1988. Sequence determination of the mumps virus HN gene. Virology 164: 318– 325.
138. Wharton, I. P.,, A. H. Chaudhry, and, M. E. French. 2006. A case of mumps epididymitis. Lancet 367: 702.
139. Wharton, M.,, S. L. Cochi,, R. H. Hutcheson,, J. M. Bistowish, and, W. Schaffner. 1988. A large outbreak of mumps in the postvaccine era. J. Infect. Dis. 158: 1253– 1260.
140. Wilfert, C. M. 1969. Mumps meningoencephalitis with low cerebrospinal fluid glucose, prolonged pleocytosis and elevation of protein. N. Engl. J. Med. 280: 855– 859.
141. Yamada, A.,, K. Takeuchi,, K. Tamabayashi,, M. Hishiyama,, Y. Takahashi, and, A. Sigiura. 1990. Differentiation of the mumps vaccine strains from the wild viruses by the nucleotide sequences of the P gene. Vaccine 8: 553– 557.
142. Zhou, F.,, S. Reef,, M. Massoudi,, M. J. Papania,, H. R. Yusuf,, B. Bardenheier,, L. Zimmerman, and, M. M. McCauley. 2004. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States. J. Infect. Dis. 189 (Suppl. 1) : S131– S145.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V.